Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Condition(s):Chorioretinal Vascular DiseaseLast Updated:September 16, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Chorioretinal Vascular DiseaseLast Updated:September 16, 2021Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 13, 2016Unknown status
Condition(s):Retinal Pigment Epithelial Detachment Secondary to Age-related Macular DegenerationLast Updated:February 16, 2017Completed
Condition(s):Glaucoma; Rubeosis IridisLast Updated:December 29, 2015Completed
Condition(s):Diabetic Macular EdemaLast Updated:September 22, 2020Unknown status
Condition(s):Corneal NeovascularizationLast Updated:September 16, 2019Terminated
Condition(s):Adenocarcinoma of the Colon; Adenocarcinoma of the RectumLast Updated:January 25, 2017Withdrawn
Condition(s):Diabetic RetinopathyLast Updated:December 30, 2016Unknown status
Condition(s):Polypoidal Choroidal VasculopathyLast Updated:November 23, 2016Completed
Condition(s):Diabetic Macular EdemaLast Updated:July 10, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.